Lucid Scientific, an Atlanta, GA-based life science instruments company, raised $7M in Series A funding.
The round, which brought the total amount to $13M, was led by IAG Capital Partners. Additional participants included the Georgia Research Alliance’s Venture Fund, and Dynamk Capital. IAG Venture Partner Dr. Ehsan Jabbarzadeh will join Lucid’s Board of Directors.
The company intends to use the funds to expand production, sales and marketing, as well as broaden new product advancements.
Led by CEO Dr. Walker Inman, Lucid Scientific is a life science instruments company working to accelerate drug discovery and fundamental biological research by providing systems for real-time cellular analysis. Its Resipher provides researchers with insights into cellular metabolism that are of central importance for a wide range of therapeutic applications and drug safety considerations. It converts standard cell culture plates into smart readers that detect and report metabolic changes in real-time. This data accelerates the cell culture research cycle by bridging the gap between performing experiments and gaining actionable insight.
FinSMEs
27/09/2023